Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde E Groot

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology|August 23, 2017
High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarctionHilde E Groot, Jacco C Karper, Erik Lipsic, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 8, 2021
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular diseaseDaan Ties, Tajinder K Singh, Xin Zhang, et al.
Journal of Clinical Medicine|December 10, 2021
Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial InfarctionMohammad A Almesned, Femke M Prins, Erik Lipšic, et al.
Scientific Reports|December 5, 2023
Fetuin-A and its genetic association with cardiometabolic diseaseLawien Al Ali, Yordi J van de Vegte, M Abdullah Said, et al.
European Journal of Heart Failure|April 5, 2024
Incidence and predictors of heart failure with reduced and preserved ejection fraction after ST-elevation myocardial infarction in the contemporary era of early percutaneous coronary interventionChris Lenselink, Kim W L M Ricken, Hilde E Groot, et al.
Cytokine|March 21, 2015
Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarctionHilde E Groot, Minke H T Hartman, Youlan L Gu, et al.
Genes|August 27, 2021
Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor TreatmentSiqi Wang, M Abdullah Said, Hilde E Groot, et al.
Atherosclerosis|January 29, 2022
Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based LifeLines DEEP cohortAnouk G Groenen, Venetia Bazioti, Isabelle A van Zeventer, et al.
BMC Cardiovascular Disorders|January 23, 2023
Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarctionLawien Al Ali, Hilde E Groot, Solmaz Assa, et al.
Plos One|December 10, 2016
Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-ReperfusionMinke H T Hartman, Inge Vreeswijk-Baudoin, Hilde E Groot, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology|August 23, 2017
High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarctionHilde E Groot, Jacco C Karper, Erik Lipsic, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 8, 2021
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular diseaseDaan Ties, Tajinder K Singh, Xin Zhang, et al.
Journal of Clinical Medicine|December 10, 2021
Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial InfarctionMohammad A Almesned, Femke M Prins, Erik Lipšic, et al.
Scientific Reports|December 5, 2023
Fetuin-A and its genetic association with cardiometabolic diseaseLawien Al Ali, Yordi J van de Vegte, M Abdullah Said, et al.
European Journal of Heart Failure|April 5, 2024
Incidence and predictors of heart failure with reduced and preserved ejection fraction after ST-elevation myocardial infarction in the contemporary era of early percutaneous coronary interventionChris Lenselink, Kim W L M Ricken, Hilde E Groot, et al.
Cytokine|March 21, 2015
Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarctionHilde E Groot, Minke H T Hartman, Youlan L Gu, et al.
Genes|August 27, 2021
Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor TreatmentSiqi Wang, M Abdullah Said, Hilde E Groot, et al.
Atherosclerosis|January 29, 2022
Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based LifeLines DEEP cohortAnouk G Groenen, Venetia Bazioti, Isabelle A van Zeventer, et al.
BMC Cardiovascular Disorders|January 23, 2023
Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarctionLawien Al Ali, Hilde E Groot, Solmaz Assa, et al.
Plos One|December 10, 2016
Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-ReperfusionMinke H T Hartman, Inge Vreeswijk-Baudoin, Hilde E Groot, et al.
Pageof 3